BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30401402)

  • 1. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.
    Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation.
    Tanemura A; Kuriyama N; Azumi Y; Ohsawa I; Kishiwada M; Mizuno S; Usui M; Sakurai H; Tabata M; Isaji S
    Transplant Proc; 2014 May; 46(4):1107-11. PubMed ID: 24815140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
    Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
    J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
    Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
    World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
    Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
    Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response.
    Li CX; Ng KT; Shao Y; Liu XB; Ling CC; Ma YY; Geng W; Qi X; Cheng Q; Chung SK; Lo CM; Man K
    Ann Surg; 2014 Aug; 260(2):317-28. PubMed ID: 24699020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
    Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
    Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
    Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
    Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Weng J; Li W; Jia X; An W
    Transplantation; 2017 Oct; 101(10):2340-2348. PubMed ID: 28704337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbated ischemia-reperfusion injury in fatty livers is mediated by lipid peroxidation stress and ferroptosis.
    Rokop ZP; Zhang W; Ghosh N; Biswas N; Das A; Lin J; Sen CK; Kubal C
    Surgery; 2024 Jun; 175(6):1539-1546. PubMed ID: 38508920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury.
    Zaouali MA; Bardag-Gorce F; Carbonell T; Oliva J; Pantazi E; Bejaoui M; Ben Abdennebi H; Rimola A; Roselló-Catafau J
    Exp Mol Pathol; 2013 Apr; 94(2):352-9. PubMed ID: 23305864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of L-selectin-guided CD8
    Kolachala VL; Palle S; Shen M; Feng A; Shayakhmetov D; Gupta NA
    Hepatology; 2017 Oct; 66(4):1258-1274. PubMed ID: 28543181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury.
    Matsuda A; Kuriyama N; Kato H; Tanemura A; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    Biomed Res Int; 2015; 2015():635041. PubMed ID: 26539519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
    Shaker ME; Trawick BN; Mehal WZ
    Biochem Pharmacol; 2016 Jul; 112():90-101. PubMed ID: 27157410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of autophagy reduces ischemia/reperfusion injury in steatotic rat livers.
    Kan C; Liu A; Fang H; Dirsch O; Dahmen U; Boettcher M
    J Surg Res; 2017 Aug; 216():207-218. PubMed ID: 28807209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.
    Kuroda S; Tashiro H; Igarashi Y; Tanimoto Y; Nambu J; Oshita A; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    J Hepatol; 2012 Jan; 56(1):146-52. PubMed ID: 21756846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
    Ben Mosbah I; Roselló-Catafau J; Alfany-Fernandez I; Rimola A; Parellada PP; Mitjavila MT; Lojek A; Ben Abdennebi H; Boillot O; Rodés J; Peralta C
    Liver Transpl; 2010 Feb; 16(2):163-71. PubMed ID: 20104484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.